Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Corporate Update

Go back to Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Corporate Update
(NASDAQ: IOVA) Delayed: 8.70 -0.09 (1.02%)
Previous Close $8.79    52 Week High
Open $8.69    52 Week Low
Day High $8.91    P/E N/A 
Day Low $8.48    EPS
Volume 9,542,875